PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Actinium Pharmaceuticals, Inc. (ATNM)
1.780.01 (-0.56%)
1.75 - 1.81
1.03 - 2.41
122.5K / 296.7K (Avg.)
-1.36 | -1.31
Gauges a company's environmental, social, and governance practices.
55.94
ESG score 90-95% of ADAP's 60.48. Bill Ackman would demand clear ESG improvement catalysts.
54.17
Environmental score 1.1-1.2x ADAP's 50.70. Guy Spier would verify if superior environmental practices translate to better regulatory positioning.
56.72
Social score 80-90% of ADAP's 67.17. Walter Schloss would scrutinize stakeholder relations and reputational exposure.
56.94
Governance score 80-90% of ADAP's 63.57. Walter Schloss would scrutinize management accountability and board independence.